Thursday, February 27, 2020

Laparoscopy Devices Market - Competitive Landscape and Key Product Segments

Gone are the days of old surgical scopes and the future belongs to minimally invasive procedures using modern surgical laparoscopes. These scopes are more like an apparatus with various parts including viewing device, CCD camera, energy supply devices, and lens cleaners. On the back of increasing percentage of obese people, the number of bariatric surgeries for weight reduction is escalating and consequently, the market for laparoscopy devices is expanding. According to the estimations of a fresh business intelligence study conducted at the headquarters of Transparency Market Research (TMR), the demand in the global laparoscopy market will multiply at a formidable CAGR of 7.1% during the forecast period of 2013 to 2019. By the end of 2019, the global laparoscopy devices market is evaluated to be worth US$12.3 billion.

Global Shares Fairly Consolidated Among a Few Players

The shares in the global laparoscopes market is quite consolidated among a handful of players, as per the findings of the TMR report. Despite growing at a significant rate, the companies operating in this market are challenging each other in terms of price as the products are expensive. As more and more advanced surgeries are performed pertaining to gynecology, gastrointestinal, and general – the vendors will have a fruitful time, although major players such as Medtronic, Karl Storz, Olympus, Ethicon, and Intuitive Surgical are expected to remain ahead of the curve.

Planning To Lay Down Future Strategy? Request Brochure Of Laparoscopy Devices Market


On the basis of equipment, the market for laparoscopy devices has been segmented into trocars, energy systems, internal closure devices, sample retrieval bag, insufflation devices, laparoscopes, hand-assist devices, gastric band, and wound protectors. Application-wise, the market has been bifurcated into gynecological surgeries, urological surgeries, colorectal surgeries, bariatric surgeries, and general surgeries. Region-wise, North America and Europe continue to generate the most potent chunk of demand for laparoscopy devices, which is a reflection of high adoption rate of new technologies in the residing countries. That being said, emerging economies of China and India have a much stronger volume of consumer base and are expected to turn Asia Pacific into a profitable region in the near future.

To Obtain All-Inclusive Information On Forecast Analysis Of Laparoscopy Devices Market , Request A Discount


Growing Adoption of Minimally Invasive Procedures Driving Demand

Increasing investments in the laparoscopic instruments market, growing number of minimally invasive procedures performed across the world, rising prevalence of colorectal cancer, increasing number of laparoscopic bariatric procedures, technological advancements, and flourishing healthcare industry in BRICS nations are some of the key drivers of the global laparoscopy devices market. On the other hand, reduction in medicare payments to healthcare providers in the U.S., increasing preference of robotic surgeries, and dearth of trained professionals to operating the sophisticated equipment are obstructing the laparoscopic devices market from attain higher profitability. Additionally, the voids in infrastructural support for laparoscopic procedures in underdeveloped nation is keeping past potential patient pool from benefitting. Nevertheless, increasing number of free-trade agreements are expected to reflect positive in the near future.

Key Takeaways

  • Global laparoscopy devices market to be worth US$12.3 billion by 2019, with the demand expanding at CAGR 7.1% during 2013 to 2019
  • Competitive landscape fairly consolidated among a small pool of players
  • North America and Europe constitute for more than half of the total demand for laparoscopic devices
More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 


Sinus Dilation Devices Market  -

Medical Fiber Optics Market Shares, Strategies, and Forecasts Analysis

The global medical fiber optics market is a consolidated one with the presence of a few large companies that hold majority market share, states Transparency Market Research (TMR) in a new research report. Product innovation and development of existing products is the focus of key players in this market to consolidate their position.
Prominent companies to name in the medical fiber optics market are Timbercon Inc., Coherent Inc., Rofin, Vitalcor Inc., Sunoptic Technologies, IPG Photonics, Schott, Leoni AG, Trumph, and American Medical System.

As per the TMR report, the global medical fiber optics market is expected to rise at a CAGR of 7.60% between 2013 and 2019. Rising at this pace, the market is anticipated to peg an overall value of US$1.3 bn by 2019 from US$863.1 mn in 2013. In terms of application, the endoscopes segment displayed dominance in the overall market in 2013; going forward, the segment is poised to display notable growth rate through 2019. The endoscopes segment is predicted to be worth US$543 mn by 2019. By geography, North America holds dominance in the medical fiber optics market as the region boasts high medical service standards and presence of state-of-the-art medical infrastructure. Furthermore, rising demand for minimally invasive surgeries will bode well for North America medical fiber optics market in the near future. North America is expected to continue to lead the global market for medical fiber optics in the forthcoming years.

Planning To Lay Down Future Strategy? Request Brochure Of Medical Fiber Optics Market

Improvement of Healthcare Infrastructure Fuels Demand

First and foremost, medical fiber optics are increasingly used in minimally invasive procedures. This is driving the medical fiber optics market. With technological advancements of medical equipment leading to shrinking of their size, the medical fiber optics market receives a boost. The global medical fiber optics market is also fuelled by rising demand for progressive technologies and expeditious development in fiber technology.

Growth of application segments of medical fiber optics is also poised to boost the medical fiber optics market. Among the key application segments of medical fiber optics, endoscopes display the leading demand

Technological advancements and improvement in healthcare infrastructure serve to provide opportunities for application segments of medical fiber optics market. This serves to boost the market. Furthermore, with rising demand for minimally invasive surgeries, the application segments of the market will receive a boost.

To Obtain All-Inclusive Information On Forecast Analysis Of Medical Fiber Optics Market , Request A Discount


Strict Regulations to Monitor Product Specifications Impedes Growth

However, despite several favorable factors fuelling demand for medical fiber optics factors such as strict regulations that monitor if specifications and standards of medical fiber optics are adhered to is a bottleneck to the market’s growth. In addition, risk associated with high intensity of fiber optic lights are some crucial factors inhibiting the global medical fiber optics market. Nevertheless, rising medical standards and improvement in healthcare infrastructure are poised to bring lucrative opportunities to the medical fiber optics market. Furthermore, diverse applications of fiber optics along with their benefits is likely to offer growth opportunities for players in the medical fiber optics market.

More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 

Sinus Dilation Devices Market  -

Sports Medicine Devices Market: Business Overview and Global Development Trends

The global sports medicine devices market is expected to find players undergoing consolidation causing the development of its oligopolistic nature. Leading players could concentrate on product differentiation, advertising, and marketing during their stay in the market. In a report by Transparency Market Research (TMR), prominent names of the market such as Össur hf., DJO Global, Inc., and ArthroCare Corporation are closely studied in the company profiling section. In the recent past, the market witnessed an acquisition agreement made between Smiths & Nephew and ArthroCare. Complementary product portfolio organized after the acquisition is anticipated to expand product pipeline and improve revenue.

TMR foretells the global sports medicine devices market to bag revenue earnings worth an US$8.2 bn by the completion of 2019. On the basis of orthopedic product, arthroscopy devices could continue taking a larger share of the market in the near term. In terms of region, the market is predicted to testify the rise of North America as a leading segment.

Planning To Lay Down Future Strategy? Request Brochure Of Sports Medicine Devices Market

People with Disabilities in Sports Activities Swells Demand

Support gained from online marketing is supposed to bode well for the world sports medicine devices market. However, there are some more important factors that could tellingly enhance market growth in the foreseeable future. For instance, encouragement given to the specially-abled to participate in sports activities could not be turned a blind eye to. Furthermore, rising awareness about fitness and health among the elderly and increase in the count of sports medicine associations are projected to set the tone for valuable growth in the market.
There are some orthopedic products that could showcase increasing demand in the world sports medicine devices market – for instance, arthroscopy devices. On the other hand, the prosthesis market is foreseen to exhibit a slow pace of growth. However, demand in the global market could increase on the back of the impressive rise of braces as star segment under support and recovery products.

To Obtain All-Inclusive Information On Forecast Analysis Of Sports Medicine Devices Market , Request A Discount


Reduction in Budget Allocation for Sports Tests Growth of Market Players

Growth of the international sports medicine devices market is forecasted to slump due to decreased budget allocation for sports. Moreover, dearth of reimbursement policies reserved for academic sports injuries could apply brakes on market growth in the coming years. However, introduction of novel implants and prosthetics and development of performance monitoring equipment are envisaged to create ample of opportunities in the market. Rising frequency of sports injuries in Asia Pacific and another region of the market could help with the demand for sports medicine devices.

Technological development on the part of joint repair implants and demand for minimally invasive procedures are envisioned to be other factors pushing market growth in the next few years.

More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 


Sinus Dilation Devices Market  -

Contraceptives Market Trends and Growth Factors Analysis

The demand within the global market for contraceptives has been rising on account of the growing incidence of sexually transmitted diseases, finds Transparency Market Research (TMR). The competitive dynamics of the global market for contraceptives have drastically changed over the past decade. The key players have resorted to informative marketing practices in order to create a regular consumer base. There is a high possibility of new business practices coming to the fore of the global contraceptives market. Moreover, the presence of established vendors in the global market for contraceptives is a key consideration for newbie vendors as well.
It is expected that strategic alliances amongst large, medium, and small-scale vendors would be a common trend in the global contraceptives years to come. This will help the larger vendors in accessing the regional markets, while the smaller vendors could learn from the strategies of the established vendors. Furthermore, mergers and acquisitions are also projected to be a key trend in the global contraceptives market in the years to come. It is safe to prognosticate that new and more effective forms of contraceptives would be introduced by the vendors in the years to come. Some of the key vendors in the global contraceptives market are Allergan plc, Mankind Pharma, Janssen Pharmaceutical Company, Mithra Pharmaceuticals, HLL Lifecare Limited, and Cipla Inc.

Planning To Lay Down Future Strategy? Request Brochure Of Contraceptives Market


Transparency Market Research (TMR) finds that the global contraceptives market would expand at a healthy CAGR of 6.10% over the period between 2017 and 2025. The cumulative value of the global contraceptives market would reach US$ 37,242.7 mn by 2025-end, rising up from a value of US$ 22,050 mn in 2016. On the basis of product, the demand for oral contraceptives is on a rise in recent times. Based on geography, the market for contraceptive in North America is expanding at a stellar pace due to growing awareness about STDs in the US and Canada.

Awareness Campaigns about STDs to Propel Demand

The rising incidence of sexually transmitted diseases has led national and international bodies to launch awareness campaigns. Several offline and online platforms have been leveraged to educate people about the need for using contraceptives. Hence, the demand within the global market for contraceptives is projected to escalate to new heights in the years to come. Furthermore, the availability of contraceptives such as condoms, vaginal rings, and pills across pharmacies has also aided market growth. Besides this, the presence of key vendors for producing various types of contraceptives has also aided market growth.

To Obtain All-Inclusive Information On Forecast Analysis Of Contraceptives Market , Request A Discount

Easy Availability of Contraceptive Devices to Propel Demand

The global market for contraceptives has expanded at a starry pace in recent times. The availability of several nascent contraceptives such as contraceptive sponges, vaginal rings, female condoms, and diaphragms has created commendable opportunities for growth within the global market. Furthermore, contraceptives are now available across a number of selling points including pharmacies, online platforms, clinics, and hospitals. This factor has also emerged as a crucial driver of demand within the global contraceptives market. Promotion of contraceptive-use across schools and colleges has also led to the growth of the global market.

More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 


Sinus Dilation Devices Market  -

Cell Based Assays Market - Major Factors Driving the Industry

Constant entry of biotechnology and pharmaceutical companies in the global cell based assays market accounts for the prevailing forces of fragmentation, notes Transparency Market Research (TMR). These companies benefit increasingly from substantial financial clout they have, which helps them leverage the forces of competition in their favor, finds TMR.

Some of the key players vying for sizeable stakes in the global cell based assays market are Danaher Corporation, Thermo fisher Scientific Inc., Marin Biologic Laboratories, Essen BioScience Inc., Enzo Life Sciences, Inc., and QGel SA.

The global cell-based assays market was worth approximately US$1.36 billion in 2017. During 2017–2022, the market is projected to expand at CAGR of 7.7% and reach a valuation of US$1.97 billion by 2022 end.
Based on end user, the biotechnology and pharmaceutical segment holds the sway in the global cell based assays market. The segment will continue to hold a major share globally in the coming few years as well. The growth is propelled by rapid application of cell-based assays in drug discovery world over.

Planning To Lay Down Future Strategy? Request Brochure Of Cell Based Assays Market

Regionally, North America accounted for the major share in the global cell-based assays market in 2017. The regional market will clock a CAGR of 8.2% during 2017–2022. The growth is fueled by substantial volumes of investments being poured into research and development activities in the region.

Widespread Application in Drug Discovery Applications propels Growth

The global cell based assays market is driven increasingly by the widespread application of the methodologies in drug discovery applications in drug making. The applications are notably bolstered by rapidly rising number of drugs for chronic diseases in various regions across the world. The prevalence of cardiovascular diseases and diabetes is also fueling the demand for cell-based assays.

There contours of the global cell based assays market is shaped by the rising demand for more efficacious drugs for various life-threatening diseases. The growing role of cell-based assays in drug discovery for cancer is a case in point.

Growing role of cell-based assays in accelerating time-to-market of drugs by pharmaceutical and biotech companies is a key trend aiding in the rapid stride of the global cell based assays market. These assays occupy notable a pivotal role in reducing the instances of late-stage drug failures. Moreover, rising demand for cell-based assays methodologies in investigational new drugs is a key trend boosting the market. Furthermore, growing number of in vitro drug studies based on cell-based assays is fueling the market’s growth.

To Obtain All-Inclusive Information On Forecast Analysis Of Cell Based Assays Market , Request A Discount


High Cost of Assay Instruments and Unfavorable Regulatory Framework hampers Prospects

However, the steady growth of the global cell-based assays market is hindered by the high cost of assay instruments and lack of suitable regulatory framework for the use of reagents. Nevertheless, the rising worldwide demand for novel drugs and treatments is also likely to create new, exciting avenues in the market. The rising use of cell-based assays in various ultra-high throughput screening also paves way for lucrative opportunities for pharmaceutical and biotech companies. Furthermore, exciting strides witnessed in synthetic biology in recent years are also underpinning the growing prospects of the global cell-based assays market.

More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 


Sinus Dilation Devices Market  -

Electronic Health Records Market - Brief Analysis by Top Key Players

Transparency Market Research reports the global electronic health records market to witness a remarkable growth in the coming years because of the fast growing digitalization. The market is very competitive with many players striving to get the dominant share in the market. The rise in funds for research and development activities in order to produce better results in terms of healthcare monitoring devices and especially electronic health records.
Major players of the global electronic health record market are Athenahealth, Inc., Medical Information Technology, LLC, Greenway Health, Allscripts Healthcare Solutions, Inc., 4medica, and McKesson Corporation. Vendors are also focusing and trying to increase the number of merger and acquisition strategies in order to increase their expansion and grab a better hold of the market share in the future.

As per the records of TMR, the global electronic health record market is presumed to be valued at US$38.29 bn by 2025, with a healthy CAGR of 5.70% within the forecast period of 2017 to 2025. As per the segmentation by installation, the global market for electronic health record is expected to be dominated by the web based electronic health records segment because of the internet and software being a service segment. This is expected to increase the growth rate of the market in the years to come.

Planning To Lay Down Future Strategy? Request Brochure Of Electronic Health Records Market

Geographically, the market is expected to be dominated by the Europe and Asia Pacific region because of the rising age old population and their growing need for healthcare monitoring. Apart from that, North America is seen to be having a stable growth rate because of the early adoption of new techniques and also early maturity of the market.

Records Make it Easier for Doctors to Keep Check on Patient’s Medical History, thus propelling market

The main factors for boosting the electronic health record market is the rise in geriatric population and the increasing number of chronic diseases which needs electronic health record in order to keep check on their personal health and accordingly take medications. Other factors to accelerate the growth of the market is the fast developing healthcare sector and the government support it is getting in order to improve the infrastructural and medical scenario of the world. Adding to this, keeping medical records has become very important both for the patient as well as for the doctor and hospital centers in order to keep tract of his health, whether there has been any improvement in the health of the patient. Records are even helpful in cases where senior doctors or specialists are consulted or when one medical case passes on from one geographical location to another.

Electronic health monitors and records also increases the adopting techniques of clinical trial management, clinical decision support system, and data mining along with other software solutions. The increase in preference and usage of these softwares also propel the market for electronic health record market in the years to come.
The use of electronic health records not only gives a better and in-detailed description of the patient’s health but also gives him a personal level satisfaction since his medical condition is not just limited to doctors but is also present in black and white so that he can rely on the computerized reports.

To Obtain All-Inclusive Information On Forecast Analysis Of Electronic Health Records Market , Request A Discount

Better Healthcare Standards to Boost Market in Long Run

Reduction in medical expenditure is also propelling the market for electronic health record in the long run. With cheaper treatment and examination rates, people from different status levels are also able to afford them and hence opting for these procedures. Adding to that, there is also rise in the standard of healthcare and medical facilities and personal medical care systems as well which is further estimated to fuel the electronics heath record market at a global level.

More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 

Sinus Dilation Devices Market  -

Dental Consumables Market Development, Trends, Segmentations Analysis

According to the latest research report by Transparency Market Research, the global dental consumables market is projected to witness an intense competition in its vendor landscape. The research report expects the top companies in the global market to account for the largest share. These leading companies accounted for around 62% of the overall market share in recent years. Because of their excellent brand values and affordable prices, these companies have been able to stay ahead of their competitive curve. Some of the key players in the global market for dental consumable include names such as Dentsply Sirona, Henry Schein Inc., Danaher Corporation among others. “These companies, with a view to bolster their market position, are projected to continue to adopt inorganic growth strategies such as mergers, takeovers, strategic alliances, partnerships, and acquisitions”, notes TMR analyst
According to the research report findings by TMR, the global dental consumable market is projected to show a healthy growth rate of 6.1% over the projection period ranging from 2016 to 2024. This CAGR is expected to help the global market to reach a valuation worth US$33.4 bn by the fall of year 2024. In terms of segmentation by product, the bridges and crowns are expected to take the maximum share and will show a CAGR of 7.2%. On the other hand, in terms of regional segmentation, the Europe market is expected to account for the largest share with 41.1%.

Planning To Lay Down Future Strategy? Request Brochure Of Dental Consumables Market

Dental Tourism in Emerging Nations is Key Driving Factor for Market Growth

“In the past few years, there has been a growing demand for dental consumables. This demand is primarily fueled by the growing dental tourism in countries such as Turkey, Hungary, and India. Moreover, emergence of newer technologies and services have also helped in pushing the development of the global market”, notes TMR analyst. A large number of customers are now attracted to undergo dental treatments because of the cost efficiency and affordable services offered in these developing countries. In addition to this, other factors such as minimal intervention by the government, early availability of newer treatment technologies, and lower labor costs are also helping to push the development of the global dental consumables market in upcoming years.

To Obtain All-Inclusive Information On Forecast Analysis Of Dental Consumables Market , Request A Discount


Success of Dental Implants is Fueling Adoption of Market

The overall development of the global dental consumables market is expected gain a solid momentum in next few years is because of the growing success rate of the new dental implants. This is particularly more successful for upper jaw treatments. This has thus led to growing adoption of several types of new procedures that consists of dental implants. Highly matured and sophisticated healthcare services in European nations such as the UK, Spain, Italy, and Greece are further expected to help the overall development of the global dental implants market.

More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 


Sinus Dilation Devices Market  -

Teleradiology Market Segments, Leading Player, Application & Forecast Analysis

Despite the presence of relatively small number of regional players and a handful of global players, the global teleradiology market is markedly fragmented, notes Transparency Market Research (TMR). Several regional players boast of sizeable shares in their respective regions, the status quo is constantly threatened by numerous large players based in developed markets, notably from Europe and North America. In order to retain their shares in the overall market, these regional companies constantly need to bolster their product portfolio and geographic reach. On the other hand, globally prominent players are capitalizing on their brand value and the strength of innovative offerings to gain a competitive edge over their rivals. 

TMR observes that the players with international presence may leverage the synergies of long-term contracts they are entering with various service providers. They are also expected to explore new revenue streams by collaborating with community hospitals and acquiring small regional vendors in emerging markets, especially present in far-flung areas. 

Planning To Lay Down Future Strategy? Request Brochure Of Teleradiology Market

names of vRad, Inc., USA Radiology Management Solutions, and Radiology Reporting Online.
The global teleradiology market stood at US$ 1.35 Bn in 2014. Expanding at a robust CAGR of 11.3% from 2015 to 2023, the opportunities in the global market is projected to reach a worth of US$3.63 Bn by the end of 2023.
Among the various regions, Asia Pacific is anticipated to be one of the most promising markets rising at potentially attractive CAGR of 12.1% during 2015–2023. The extensive regional demand is attributed mainly to rapid advancements in the healthcare sector across its key economies. 
The various modalities used in teleradiology are ultrasound, X-Ray, computed tomography (CT), nuclear imaging, and magnetic resonance imaging. Of these, the demand for CT procedures is expected to be lucrative throughout the assessment timeline.

Demand Fueled by Rapid Advances in Telecommunication Technologies

The substantial drive that teleradiology has witnessed over the past few years stems from the need for meeting the burgeoning demand for radiology services in various parts of the world. The growth of the teleradiology market is increasingly fueled by the rapid advances being made in the internet and communication technologies (ICT) used in the healthcare industries. The attractive strides being made by healthcare IT in developing and developed countries is propelling the growth of the market.

The rising need for transmission of radiological images using a range of digital technologies supported by telecommunication in medical emergencies is bolstering the demand for teleradiology. Recent advancements in web technologies in healthcare systems, notably wireless image transmission systems, have boosted the market.
The demand for teleradiology services in rural areas in several emerging economies is also vast. This is attributed to the lack of adequate radiological systems and the paucity of trained personnel in remote areas of these regions. The paucity of specialty expertise in urban centers in numerous emerging economies is also fostering the demand for teleradiology.

To Obtain All-Inclusive Information On Forecast Analysis Of Teleradiology Market , Request A Discount

High Cost of Setting Teleradiology Infrastructures may Retard Growth

The global teleradiology market is witnessing lucrative prospects from advancements being made in various digital image processing methods in developing regions. However, the growth is notably beset by the high cost of setting up infrastructures for teleradiology, given the lack of funds in emerging economies in several parts of the world. Add to this, the glaring lack of a reliable internet connection or poor state of broadband connections in rural areas is a significant deterrent to the steady expansion in the global market. The presence of subspecialty expertise in various imaging centers is further retarding the uptake of teleradiology in these regions.

Nevertheless, the rising demand for radiology outsourcing, coupled with the substantially increasing disposable incomes of urban populations, in various parts of the world is expected to fuel the expansion of the market over the next five years. Favorable governmental healthcare policies for setting up teleradiology systems in numerous emerging economies also augur well for the overall market.

More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 


Sinus Dilation Devices Market  -

Neurotrophic Keratitis Market Key Players, Industry Overview and Forecast Analysis

Neurotrophic Keratitis Market: Introduction

Transparency Market Research has published a new report titled, “Global Neurotrophic Keratitis Market”. According to the report, the global neurotrophic keratitis market was valued at US$ 91.6 Mn in 2018 and is projected to expand at a CAGR of ~17% from 2019 to 2027. Rise in reported cases of keratitis, increase in research & developmental activities, surge in awareness, and rise in co-morbidities & risk factors boost the growth of the global neurotrophic keratitis market.

Pharmacotherapies using Drugs to Lead Global Market

In terms of treatment type, the drugs segment accounted for major share of the global neurotrophic keratitis market in 2018. The segment is anticipated to witness strong growth from 2019 to 2027. The drugs segment has been sub-segmented into artificial tears, recombinant human nerve growth factor eye drop, antibiotics, bandage contact lens, and others. The artificial tears sub-segment accounted for major share of the drugs segment in 2018. However, the recombinant human nerve growth factors eye drops sub-segment is expected to account for major share by 2027, as these eye drops restore the normal healing process of the eye and repair corneal damage. The drugs segment’s major market share is due to increase in clinical studies, approvals, and launch of various novel products. In February 2019, ReGenTree initiated the ARISE-3 study, the phase 3 clinical trial of the new drug RGN-259 for the treatment of dry eye syndrome. In August 2018, Dompé announced the U.S. Food and Drug Administration (FDA) approval for cenegermin (Oxervate), a breakthrough therapy for neurotrophic keratitis (NK), which is a rare and progressive eye disease that can lead to corneal scarring and vision loss.

Planning To Lay Down Future Strategy? Request Brochure Of Neurotrophic Keratitis Market

Stage II Neurotrophic Keratitis to Remain Significant

Based on application, the stage I segment held major share of the global neurotrophic keratitis market in 2018. However, the stage II segment is projected to capture the largest share of the global market by 2027. Dominance of the stage I segment in 2018 can be ascribed to off-label availability of products for stage I, high prevalence of early symptoms in stage I, and high demand for preservative-free artificial tears during the first half of the forecast period. Symptoms of stage II neurotrophic keratitis help in diagnosis of the disease. A study published in 2014 titled, “Diagnosis and management of neurotrophic keratitis”, stated that stage II NK is characterized by recurrent and/or persistent epithelial defects (PED) with an oval or circular shape, most frequently localized at the superior half of the cornea. Diagnosis of NK is primarily based on the clinical history of conditions associated with trigeminal impairment, presence of PED or ulcers, and decreased corneal sensitivity.

A study published in Elsevier, Inc. in November 2017 indicated that around 34% of total studied patients in Italy were affected by persistent epithelial defects (PED) of stage II. Hence, the growth of the stage II segment can be ascribed to rise in awareness about and rate of diagnosis of the disease, launch of products which are effective in stage II persistent epithelial defects treatment, and surge in inclination of patients toward specialized centers for receiving advanced treatment.

To Obtain All-Inclusive Information On Forecast Analysis Of Neurotrophic Keratitis Market , Request A Discount


Neurotrophic Keratitis Market: Prominent Regions

North America held the largest share of the global neurotrophic keratitis market in 2018. The market in the region is projected to grow at a rapid pace during the forecast period, driven by presence of key players, technological advancements, and highly structured healthcare industry. Increase in clinical trials, product launches, and approvals, and rise in investment by key players are projected to propel the neurotrophic keratitis market in North America. The U.S. is anticipated to dominate the neurotrophic keratitis market in the region during the forecast period, owing to early adoption of technologies. The country is expected to be the most attractive market for neurotrophic keratitis treatment products, with high attractiveness index. Well-equipped hospitals, technological advancements, rise in research & development on neurotrophic keratitis for novel treatment and appropriate cure, and surge in demand for novel products & treatments are likely to augment the neurotrophic keratitis market in the U.S.

Neurotrophic Keratitis Market: Key Players

Key players in the global neurotrophic keratitis market focus on strengthening their positions in the global market. Players are collaborating with other companies, actively conducting research studies, participating in mergers & acquisitions, and increasing product approvals and launches to secure and strengthen their positions in the global neurotrophic keratitis market. In April 2019, Neuroptika announced positive data from the company's phase 1 clinical trial to determine the safety, tolerability, and pharmacokinetics of topical NRO-1 in healthy subjects. NRO-1 is a novel therapeutic, with the potential to protect and regenerate corneal nerves in ophthalmic diseases. In July 2017, Dompé announced that the European Commission had granted marketing authorization of cenegermin eye drops for the treatment of moderate to severe neurotrophic keratitis.

Major players operating in the global neurotrophic keratitis market include Dompe farmaceutici S.p.A., Allergan, ReGenTree, LLC, Alcon, Bausch & Lomb Incorporated (Bausch Health Companies Inc.), CONTACARE, ROHTO Pharmaceutical Co., Ltd., Pfizer, Inc., Neuroptika, Santen Pharmaceutical Co., Ltd., Johnson & Johnson, Grand Pharma (China) Co., Ltd., and Zhejiang CONBA Pharmaceutical Co., Ltd.

More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 


Sinus Dilation Devices Market  -

Roadside Drug Testing Devices Market - SWOT Analysis of Major Industry Segments

Roadside Drug Testing Devices Market: Introduction
Transparency Market Research has published a new report titled, ‘Global Roadside Drug Testing Devices Market’. According to the report, the global roadside drug testing devices market was valued at US$ 652 Mn in 2018 and is projected to expand at a CAGR of ~4% from 2019 to 2027.

Stringent Law Enforcement to Drive Adoption of Advanced Roadside Drug Testing Devices

Drug-impaired driving has emerged as a major public health issue. Alcohol and psychoactive drugs affect an individual’s ability to drive a motor vehicle safely. Increase in number of drug and alcohol abusers across the world presents significant opportunities for the test providers and manufacturers of drug abuse test products. According to the National Institute of Drug Abuse, alcohol, tobacco, and illicit drugs create an economic burden of nearly US$ 740 Bn in the U.S. in terms of related costs, lost work productivity, and healthcare. Technological advancements related to sample collection and efforts of manufacturers to create easy-to-use disposable test kits are expected to increase the demand for drug abuse testing products. Manufacturers focus on using samples other than urine such as sweat and hair, which are less embarrassing for individuals tested for drug abuse. Manufacturers also focus on development of rapid tests that provide faster results, are easy to use, and affordable compared to the tests conducted in laboratories.

Planning To Lay Down Future Strategy? Request Brochure Of Roadside Drug Testing Devices Market

Devices for Testing Alcohol Abuse to Witness High Demand

In terms of substance, the alcohol segment held major share of the global roadside drug testing devices market in 2018. The segment is projected to dominate the global market during the forecast period. The alcohol segment is anticipated to expand at a CAGR of ~4% from 2019 to 2027. Rise in consumption of alcohol and increase in incidence of driving under the influence of alcohol accelerate the growth of the global roadside drug testing devices market. Moreover, increase in approvals of roadside drug testing devices and rise in the impact of alcohol abuse on public health contribute to the growth of the global market.

Breath Analyzers to Lead Global Market

Based on sample type, the others segment, which includes breath, hair, and blood, accounted for significant share of the global roadside drug testing devices market in 2018. The segment is expected to expand at a moderate CAGR during the forecast period. Breath is the most common sample used for the detection of alcohol. Alcohol is the most widely used substance of abuse among drivers. According to data provided by the European DRUID project, alcohol is used by 3.48% drivers, illicit drugs by 1.90%, medicinal drugs by 1.36%, drug-drug combination by 0.39%, and alcohol-drug combination by 0.37%. The saliva segment is likely to witness strong growth during the forecast period. Roadside oral fluid or saliva testing is primarily being used in several countries to detect the presence of drugs. Countries such as Germany, Belgium, France, and Australia use saliva testing for identification of individuals driving under the influence of drugs (DUID).

To Obtain All-Inclusive Information On Forecast Analysis Of Roadside Drug Testing Devices Market , Request A Discount


Roadside Drug Testing Devices Market: Prominent Regions

North America held major share of the global roadside drug testing devices market in 2018. The market in the region is driven by presence of key players, high prevalence of driving under the influence of alcohol & illicit drugs, and growth strategies adopted by market players, including product approvals and launch, mergers, and acquisitions. According to Centers for Disease Control and Prevention (CDC) estimates, around 20.5 million people in the U.S. were reported driving under the influence of alcohol in 2018. Europe held the second largest share of the global roadside drug testing devices market in 2018.

Growth of the roadside drug testing devices market in the region can be attributed to rise in cases of driving under the influence of alcohol and increase in government initiatives to control road accidents & fatalities in various countries in Europe. Asia Pacific accounted for significant share of the global roadside drug testing devices market in 2018. The market in the region is projected to grow at a rapid pace during the forecast period. According to various studies, alcohol consumption is rising across Asia Pacific. Heavy episodic (binge) alcohol use has increased significantly in China, Thailand, Timor-Leste, and Vietnam. Rise in use of alcohol and other illicit drugs in the region is anticipated to drive the market in Asia Pacific during the forecast period. Moreover, implementation of strict driving laws in different countries in Asia Pacific can be attributed to the growth of the market in the region.

Roadside Drug Testing Devices Market: Key Players

Key players focus on strengthening their positions in the global roadside drug testing devices market. Rise in road fatalities due to drug-impaired driving has led to adoption of strict laws and regulations in several countries. This presents lucrative opportunities to key players to increase their share in the roadside drug testing devices market. Manufacturers are adopting strategies such as acquisitions, collaborations, and distribution to increase share in the global roadside drug testing devices market. In August 2019, Abbott and Intoximeters signed an agreement according to which, Intoximeters will market Abbott's SoToxa Mobile Test System (a handheld oral fluid roadside testing solution that rapidly and reliably detects recent drug use) along with its Alco-Sensor brand breath alcohol-testing products. This agreement will aid law enforcement agencies in their efforts to reduce the rate of drug driving, which has become a serious road safety issue.

Prominent players operating in the global roadside drug testing devices market are Drägerwerk AG & Co. KgaA, Abbott Laboratories, Oranoxis, Inc., CareHealth America, MAVAND Solutions GmbH, Pacific Data Systems Pty Ltd., Securetec, and UriTox, LLC.

More Trending Reports by Transparency Market Research –

In-vitro Colorectal Cancer Screening Tests Market - 


Sinus Dilation Devices Market  -

Wednesday, February 26, 2020

Fetal Monitoring Systems Market Size to Expand Significantly by the End of 2027

Fetal Monitoring Systems Market: Introduction
Transparency Market Research has published a new report titled “Fetal Monitoring Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”. According to the report, the global fetal monitoring systems market was valued at approximately US$ 2.8 Bn in 2018. It is expected to expand at a CAGR of ~3% during the forecast period from 2019 to 2027. Monitoring procedures are the basis to evaluate the clinical state of patients and to access changes in their conditions, thus providing necessary interventions in time. Traditional fetal monitoring systems received a fundamental improvement by new technological devices allowing longer and deeper data collection of fetus and mother. Expansion of the global fetal monitoring systems market can be attributed to rise in prevalence rate of birth asphyxia, fat gain during pregnancy, and number of preterm births worldwide. North America is a highly lucrative market for fetal monitoring systems due to mandatory fetal monitoring of pregnant women and rise in number of users of home-based fetal monitoring systems.
Planning To Lay Down Future Strategy? Request Brochure Of Fetal Monitoring Systems Market
Rise in Awareness among Pregnant Women with High Body Mass Index to Drive Fetal Monitoring Systems Market
According to the data from the Public Library of Science, the percentage of overweight women during pregnancy increased from 29.8% in 1980 to 38.0% in 2013 globally. Prevalence of excessive gestational weight gain and obesity during all trimesters is a major cause of concern for fetus health. Moreover, doctors advise regular monitoring of fetus and the mother till successful delivery. This, in turn, is driving the market.

Development of Portable Fetal Monitoring Systems to Drive Global Market

Based on product, the global fetal monitoring systems market has been divided into systems and accessories. The systems segment dominated the global fetal monitoring systems market in 2018. Expansion of the segment can be attributed to development of portable fetal monitoring systems for home use and rise in number of hospitals.

Hospitals & Nursing Homes to be key End Users

Based on end user, the global fetal monitoring systems market has been classified into hospitals & nursing homes, clinics, and home settings. Hospitals & nursing home is projected to be a highly lucrative segment from 2019 to 2027 and hold major share in terms of end-user. However, the home settings segment is anticipated to expand at a high CAGR during the forecast period. Rise in awareness about the advantages of fetal monitoring such as low cost of expenses from hospitals and development of convenient fetal monitoring systems for home use are some factors due to which home settings is expected to grow at faster rate.

To Obtain All-Inclusive Information On Forecast Analysis Of Fetal Monitoring Systems Market , Request A Discount


North America to Dominate Fetal Monitoring Systems Market

In terms of region, the global fetal monitoring systems market has been divided into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global fetal monitoring systems market in 2018. Favorable reimbursement facilities, high awareness among patients for fetal monitoring, quick adoption of advanced technology fetal monitoring systems, and presence of major players who constantly promote their brands through wide distribution channels are key factors driving the market in the region. Asia Pacific is a lucrative market for fetal monitoring systems, due to large number of preterm birth rate in the region, rise in awareness about the advantages of home monitoring, and rise in disposable income in countries in the region, such as India.

Competition Landscape

Abbott, F. Hoffmann-La Roche Ltd, and Siemens Healthineers AG are a few leading players operating in the fetal monitoring systems market. The global fetal monitoring systems market is fragmented in terms of number of players. Key players in the global market include Koninklijke Philips N.V., GE Healthcare, Mindchild Medical, Inc., Nemo Healthcare, Huntleigh Healthcare Limited (Arjo), Edan Instrument Inc., Neoventa Medical AB, Clinical Innovations, LLC., and SUNRAY MEDICAL APPARATUS CO.,LTD. New product approvals for specific indication, widespread distribution channels, and higher R&D investment are key strategies adopted by major players operating in the market.